Company:  ADAPTIVE BIOTECHNOLOGIES ... (ADPT)
Form Type:  4
Filing Date:  3/8/2022 
CIK:  0001478320 
Address:  1165 EASTLAKE AVE E 
City, State, Zip:  SEATTLE, Washington 98109 
Telephone:  206-659-0067 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$6.50  
Change: 
-0.40 (-5.80%)  
Trade Time: 
Sep 23  
Market Cap: 
$928.67M
Trade ADPT now with

© 2022  
Description of Business
We are advancing the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature's most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our immune medicine platform applies our proprietary technologies to read the diverse genetic code of a patient's immune system and aims to understand precisely how the immune system detects and treats disease in that patient. We capture these insights in our dynamic clinical immunomics database, which is underpinned by computational biology and machine learning, and use these insights to develop and commercialize clinical products and services that we are tailoring to each individual patient.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES